Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.39 |
| ▸ | CCR8 | P51685 | 1/20 | 0.39 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12154379 | 0.83 | MEN1 (0.40) | FGFR2ALDH1A1LOXL2MAPTKMT2A | |
| SCHEMBL1897179 | 0.78 | ERBB2 (0.55) | FGFR2ALDH1A1HTTLOXL2KDM4E | |
| SCHEMBL9909764 | 0.78 | LTA4H (0.41) | LTA4HTSHRFGFR2ALDH1A1HTT | |
| SCHEMBL12154377 | 0.77 | MEN1 (0.57) | ALDH1A1HTTPDGFRAKDM4EMAPT | |
| SCHEMBL22659349 | 0.74 | EGFR (0.57) | FGFR2PDGFRAKITALKKDR | |
| SCHEMBL7463576 | 0.74 | APP (0.52) | TSHRFGFR2ALDH1A1PDGFRAGLA | |
| SCHEMBL19633787 | 0.74 | FGFR2 (0.48) | LTA4HFGFR2ALDH1A1PDGFRAKIT | |
| SCHEMBL4990365 | 0.73 | SLC40A1 (0.50) | LTA4HHTTKDM4EMAPTKMT2A | |
| SCHEMBL25466495 | 0.73 | FGFR2 (0.60) | FGFR2PDGFRAKITKDR | |
| SCHEMBL4865360 | 0.73 | LTA4H (0.49) | LTA4HTSHRALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230050869-A1 | THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| EP-3902021-A1 | THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH | Toyo Ink SC Holdings Co., Ltd. (JP) | 2021-10-27 | — | — | EP | disclosed |
| EP-1681282-B1 | METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE | SUMITOMO CHEMICAL CO (JP) | 2013-01-23 | — | — | EP | disclosed |
| US-7393971-B2 | Method for producing 3,3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-07-01 | — | — | US | disclosed |
| US-20070078278-A1 | Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2007-04-05 | — | — | US | disclosed |
| EP-1681282-A1 | METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE | Sumitomo Chemical Company, Limited (JP) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078278-A1 | Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate | AOC3, PDXK, AIPL1 | LTA4H 2299/4885TSHR 4257/4885FGFR2 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.